Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Regeneron Pharmaceuticals
Novartis
Shattuck Labs, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Amgen
UNC Lineberger Comprehensive Cancer Center
Nurix Therapeutics, Inc.
Bicara Therapeutics
Xencor, Inc.
Toray Industries, Inc
Context Therapeutics Inc.
Arsenal Biosciences, Inc.
Lyell Immunopharma, Inc.
University of Pennsylvania
Dana-Farber Cancer Institute
Theratechnologies
University of Washington
Exelixis